DOI QR코드

DOI QR Code

Rutin Improves Bone Histomorphometric Values by Reduction of Osteoclastic Activity in Osteoporosis Mouse Model Induced by Bilateral Ovariectomy

  • Lee, Hye-Hwa (Research Institute of Medical Sciences, Chonnam National University) ;
  • Jang, Jae-Won (Research Institute of Medical Sciences, Chonnam National University) ;
  • Lee, Jung-Kil (Research Institute of Medical Sciences, Chonnam National University) ;
  • Park, Choon-Keun (Department of Neurosurgery, Leon Wiltse Memorial Hospital)
  • Received : 2019.04.15
  • Accepted : 2019.06.28
  • Published : 2020.07.01

Abstract

Objective : Osteoporosis is a disease of unbalanced bone metabolism that results in low bone mineral density with increased bone fragility and propensity for fractures. The increased rate of bone fracture due to osteoporosis places a significant burden on public health care expenditures. Therefore, numerous studies have been designed and performed to identify the drugs or health foods that can improve the bone quality or quantity. This study was designed to evaluate and analyze the therapeutic effects of rutin on histomorphometric values of the spine and femur in an osteoporotic mouse model induced by bilateral ovariectomy. Methods : Thirty female ICR mice (8 weeks old) underwent either a sham operation (only abdominal incision, sham group, n=10) or bilateral ovariectomy (n=20). The ovariectomized (OVX) animals were randomly divided into two groups : untreated OVX group (OVX-C, n=10), or rutin-administered group (OVX-R, n=10). The OVX-C group received weight-adjusted doses of saline vehicle and the OVX-R group received 50 mg/kg of rutin intraperitoneally, starting 1 day after surgery. At 4 and 8 weeks after surgery, serum estrogen, osteocalcin, alkaline phosphatase (ALP), and the telopeptide fragment of type I collagen C-terminus (CTX-1) were analyzed. Interleukin (IL)-1β, IL-6, IL-10, and tumor necrosis factor (TNF)-α were also analyzed. Bone histomorphometric parameters of the 4th lumbar vertebra and femur were determined by micro-computed tomography. Results : In OVX-C group, ALP, osteocalcin, CTX-1, IL-1β, IL-6, and TNF-α levels were significantly increased at 4 and 8 weeks compared to sham operation group. Rutin administration after OVX statistically significantly reduced ALP, CTX-1, IL-1β, IL-6, and TNF-α levels at 4 and 8 weeks. Rutin administration also improves bone histomorphometric parameters including trabecular bone volume fraction, trabecular thickness, and trabecular number. Trabecular separation was also decreased in OVX-R group compared to OVX-C group. Conclusion : The present study demonstrated that rutin has therapeutic effects on improving bone histomorphometric values in an OVX mouse model. The improvement in histomorphometric values may be associated with the reduction of osteoclastic activity via inhibition of IL-1β, IL-6, and TNF-α. In future studies, the mechanism for the effect of rutin on osteoporosis should be demonstrated more clearly to use rutin in human osteoporosis.

Keywords

References

  1. Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, et al. : The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12 : 903-908, 2001 https://doi.org/10.1007/s001980170017
  2. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A : Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22 : 465-475, 2007 https://doi.org/10.1359/jbmr.061113
  3. Cho DC, Kim KT, Jeon Y, Sung JK : A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat. Acta Neurochir (Wien) 154 : 2215-2223, 2012 https://doi.org/10.1007/s00701-012-1516-9
  4. Ersan N, van Ruijven LJ, Bronckers AL, Olgac V, Ilguy D, Everts V : Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model. Dentomaxillofac Radiol 43 : 20130144, 2014 https://doi.org/10.1259/dmfr.20130144
  5. Ferretti M, Bertoni L, Cavani F, Zavatti M, Resca E, Carnevale G, et al. : Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis. J Anat 217 : 48-56, 2010 https://doi.org/10.1111/j.1469-7580.2010.01242.x
  6. French DL, Muir JM, Webber CE : The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin. Phytomedicine 15 : 1069-1078, 2008 https://doi.org/10.1016/j.phymed.2008.06.007
  7. Giuliani N, Pedrazzoni M, Passeri G, Negri G, Impicciatore M, Girasole G : Bisphosphonates stimulate the production of basic fibroblast growth factor and the formation of bone marrow precursors of osteoblasts. New findings about their mechanism of action. Minerva Med 89 : 249-258, 1998
  8. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP : Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 15 : 2251-2258, 2000 https://doi.org/10.1359/jbmr.2000.15.11.2251
  9. Isai M, Sakthivel M, Ramesh E, Thomas PA, Geraldine P : Prevention of selenite-induced cataractogenesis by rutin in Wistar rats. Mol Vis 15 : 2570-2577, 2009
  10. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N : The diagnosis of osteoporosis. J Bone Miner Res 9 : 1137-1141, 1994 https://doi.org/10.1002/jbmr.5650090802
  11. Kaptoge S, Beck TJ, Reeve J, Stone KL, Hillier TA, Cauley JA, et al. : Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res 23 : 1892-1904, 2008 https://doi.org/10.1359/jbmr.080802
  12. Korkmaz A, Kolankaya D : Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J Surg Res 164 : 309-315, 2010 https://doi.org/10.1016/j.jss.2009.03.022
  13. Kyung TW, Lee JE, Shin HH, Choi HS : Rutin inhibits osteoclast formation by decreasing reactive oxygen species and TNF-alpha by inhibiting activation of NF-kappaB. Exp Mol Med 40 : 52-58, 2008 https://doi.org/10.3858/emm.2008.40.1.52
  14. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL : TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106 : 1481-1488, 2000 https://doi.org/10.1172/JCI11176
  15. Lumachi F, Frigo AC, Basso U, Tombolan V, Ermani M : Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis. Menopause 17 : 524-528, 2010 https://doi.org/10.1097/gme.0b013e3181ca0c74
  16. Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C : Bioavailability of rutin and quercetin in rats. FEBS Lett 409 : 12-16, 1997 https://doi.org/10.1016/S0014-5793(97)00467-5
  17. Middleton ET, Steel SA, Aye M, Doherty SM : The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate. J Bone Miner Res 25 : 455-462, 2010 https://doi.org/10.1359/jbmr.090821
  18. Omi N, Ezawa I : The effect of ovariectomy on bone metabolism in rats. Bone 17 : 163S-168S, 1995
  19. Pabon M, Tamboli C, Tamboli S, Acosta S, De La Pena I, Sanberg PR, et al. : Estrogen replacement therapy for stroke. Cell Med 6 : 111-122, 2014 https://doi.org/10.3727/215517913X672263
  20. Palumbo C, Ferretti M, Bertoni L, Cavani F, Resca E, Casolari B, et al. : Influence of ferutinin on bone metabolism in ovariectomized rats. I: role in preventing osteoporosis. J Bone Miner Metab 27 : 538-545, 2009 https://doi.org/10.1007/s00774-009-0070-x
  21. Pazianas M, Abrahamsen B : Safety of bisphosphonates. Bone 49 : 103-110, 2011 https://doi.org/10.1016/j.bone.2011.01.003
  22. Reszka AA, Rodan GA : Mechanism of action of bisphosphonates. Curr Osteoporos Rep 1 : 45-52, 2003 https://doi.org/10.1007/s11914-003-0008-5
  23. Shin YH, Cho DC, Yu SH, Kim KT, Cho HJ, Sung JK : Histomorphometric analysis of the spine and femur in ovariectomized rats using micro-computed tomographic scan. J Korean Neurosurg Soc 52 : 1-6, 2012 https://doi.org/10.3340/jkns.2012.52.1.1
  24. Songpatanasilp T, Mumtaz M, Chhabra H, Yu M, Sorsaburu S : Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population. Singapore Med J 55 : 493-501, 2014 https://doi.org/10.11622/smedj.2014120
  25. Thompson DD, Simmons HA, Pirie CM, Ke HZ : FDA guidelines and animal models for osteoporosis. Bone 17 : 125S-133S, 1995
  26. Watts NB, Nolan JC, Brennan JJ, Yang HM; ESTRATAB/Osteoporosis Study Group : Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study. Menopause 7 : 375-382, 2000 https://doi.org/10.1097/00042192-200011000-00002
  27. Weber M, Uehlinger K, Gerber H : Osteoporotic vertebral compression fracture causing neurologic deficit. J Clin Rheumatol 8 : 166-173, 2002 https://doi.org/10.1097/00124743-200206000-00010
  28. Yang MW, Wang TH, Yan PP, Chu LW, Yu J, Gao ZD, et al. : Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine 18 : 205-213, 2011 https://doi.org/10.1016/j.phymed.2010.05.011
  29. Zhang Q, Chen B, Yan F, Guo J, Zhu X, Ma S, et al. : Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases. Biomed Res Int 2014 : 284836, 2014 https://doi.org/10.1155/2014/284836

Cited by

  1. Ethanol Extract of Amomum tsao-ko Ameliorates Ovariectomy-Induced Trabecular Loss and Fat Accumulation vol.26, pp.4, 2020, https://doi.org/10.3390/molecules26040784